Warren K. Bickel, PhD
Professor, Virginia Tech Carilion Research Institute
Director, Addiction Recovery Research Center
Professor of Psychology, College of Science, Virginia Tech
Professor of Psychiatry and Behavioral Medicine, Virginia Tech Carilion School of Medicine
Fundamental to solving the problem of addiction and other dysfunctional health behaviors is to understand how an individual continues to engage in a behavior despite recognizing that this behavior is both problematic and self-handicapping. The Addiction Recovery Research Center seeks to answer this and related questions by examining decision-making processes that support dysfunctional behaviors and seeks novel therapeutic means to repair those dysfunctional processes. Projects include the translational assessment of dysfunctional decision-making among the addicted and using that knowledge to explore of diverse interventions to treatment and improve the decision-making dysfunction. A central tenet of this research is that trans-disease processes undergird the expression of a variety of self-handicapping decisions and that successful treatments will be applicable across those diseases.
For a more complete listing of Warren Bickel's publications, visit PubMed.
Education and Training
- Johns Hopkins University School of Medicine: Postdoctoral fellowship
- University of North Carolina Chapel Hill: Postdoctoral fellowship
- University of Kansas: PhD, Developmental and Child Psychology
- University of Kansas: MA, Developmental and Child Psychology
- University of New York New Paltz: BA, Psychology
University of Arkansas for Medical Sciences
Wilbur D. Mills Professor of Alcoholism and Drug Abuse Prevention, Department of Psychiatry
Professor, Department of Health Behavior
Director, Center for Addiction Research
Director, Interdisciplinary Tobacco Program
University of Vermont College of Medicine
Inaugural Director, Chittenden Center, An Addictions Treatment Program; Program of the Howard Center for Human Services in Alliance with Fletcher Allen Health Care and the University of Vermont's College of Medicine
Interim Chair, Department of Psychiatry
Professor, Departments of Psychiatry and Psychology
Vice-Chair for Research, Department of Psychiatry
Albert Einstein College of Medicine of Yeshiva University
Assistant Director for Clinical Research, Division of Substance Abuse
Assistant Professor, Department of Psychiatry
Awards and Honors
- Fellow, Academy of Behavioral Medicine Research, 2014
- Distinguished Alumni Award, University of Kansas, 2014
- Service as Past President Recognition, Division 50, Society of Addiction Psychology, American Psychological Association, 2013
- Scholar of the Week, Virginia Tech, 2012
- Recipient, Brady-Schuster Award for outstanding behavioral science research in psychopharmacology and substance abuse, Division 28 of the American Psychological Association, 2012
- Selected as a Distinguished Scientist Lecturer by the American Psychological Association's Science Directorate and Board of Scientific Affairs, 2012
- APA International Don Hake Translational Research Distinguished Contributions to Basic Research Award, 2011
- Fellow, Association for Behavior Analysis International, 2011
- Dean's Distinguished Faculty Leadership Award, College of Medicine, University of Arkansas for Medical Sciences, 2009
- Researcher of the Year, Arkansas Psychological Association Honors for Outstanding Contribution, 2006
- University Scholar Award, University of Vermont, 2000
- MERIT (Method to Extend Research in Time) Award Recipient, National Institute on Drug Abuse, 1997–2007
- Joseph Cochin Young Investigator Award, College on Problems of Drug Dependence, 1995
- Young Psychopharmacologist Award, Division of Psychopharmacology, American Psychological Association, 1988
- Graduate Student Travel Award, Office of Research and Graduate Studies, University of Kansas, 1980
- Outstanding Senior Award, State University of New York at New Paltz, 1978
- Gerald Lazar Memorial Award for Outstanding Senior, Psychology Department, State University of New York at New Paltz, 1978
- New York State Regents Scholarship Award, 1974
- Bickel WK, Quisenberry AJ, Snider SE. (2016). Does impulsivity change rate dependently following stimulant administration? A translational selective review and re-analysis. Psychopharmacology 233(1), 1-18.
- Wilson AG, Franck CT, Mueller ET, Landes RD, Kowal BP, Yi R, Bickel WK. (2015). AddictiveBehaviors. .
- Worley M, Shoptaw SJ, Bickel WK, Ling W. (2015). Using behavioral economics to predict opioid use during prescription opioid dependence treatment. Drug and Alcohol Dependence 148, 62-8.
- Wesley MJ, Lohrenz T, Koffarnus MN, McClure SM, De La Garza R 2nd, Salas R, Thompson-Lake DG, Newton TF, Bickel WK, Montague PR. (2014). Choosing Money over Drugs: The Neural Underpinnings of Difficult Choice in Chronic Cocaine Users. J Addict 2014, 2014:189853. doi: 10.1155/2014/189853. Epub Aug 14.
- Sheffer CE, Christensen DR, Landes R, Carter LP, Jackson L, Bickel WK. (2014). Delay discounting rates: A strong prognostic indicator of smoking relapse. Addictive Behaviors.
- Koffarnus MN, Bickel WK. (2014). A 5-Trial Adjusting delay discounting task: accurate discount rates in less than one minute. Experimental and Clinical Psychopharmacology 22(3), 222-8.
- Bickel WK, Moody L, Quisenberry AJ, Ramey CT, Sheffer CE. (2014). A competing neurobehavioral decision systems model of SES-related health and behavioral disparities. Preventative Medicine 68, 37-43.
- McClure SM, Bickel WK. (2014). A dual systems perspective on addiction: Contributions from neuroimaging and cognitive training. Annals of the New York Academy of Sciences.
- Opitz A, Legon W, Rowlands A, Bickel WK, Paulus W, Tyler WJ. (2013). Physiological observations validate finite element models for estimating subject-specific electric field distributions induced by transcranial magnetic stimulation of the human motor cortex. Neuroimage 81, 253-64.
- Oliveto A, Mancino M, Sanders N, Cargile C, Guise JB, Bickel W, Gentry WB. (2013). Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure. Eur J Pharmacol 715(1), 424-35.